Follow
Mehmet Sen
Mehmet Sen
Consultant Clinical oncologist , SJIO
Verified email at nhs.net
Title
Cited by
Cited by
Year
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ...
The Lancet 393 (10166), 51-60, 2019
8922019
Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines
V Paleri, TG Urbano, H Mehanna, C Repanos, J Lancaster, T Roques, ...
The Journal of Laryngology & Otology 130 (S2), S161-S169, 2016
1392016
Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy
DC Oksuz, RJ Prestwich, B Carey, S Wilson, MS Senocak, A Choudhury, ...
Radiation oncology 6, 1-11, 2011
932011
Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules
M Cengiz, E Özyar, M Esassolak, M Altun, M Akmansu, M Şen, Ö Uzel, ...
International Journal of Radiation Oncology* Biology* Physics 63 (5), 1347-1353, 2005
852005
Prognostic factors in lung cancer with brain metastasis
M Şen, AS Demiral, R Çetingöz, H Alanyali, F Akman, D Şentürk, M Kinay
Radiotherapy and oncology 46 (1), 33-38, 1998
801998
Prognostic significance of EGF receptor expression in early glottic cancer
AN Demiral, S Sarıoglu, B Birlik, M Sen, M Kınay
Auris Nasus Larynx 31 (4), 417-424, 2004
722004
Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: a role for a prophylactic gastrostomy?
GF Williams, MTW Teo, M Sen, KE Dyker, C Coyle, RJD Prestwich
Oral oncology 48 (5), 434-440, 2012
712012
Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma
D Bird, AF Scarsbrook, J Sykes, S Ramasamy, M Subesinghe, B Carey, ...
BMC cancer 15, 1-10, 2015
672015
Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors
C Conway, R Chalkley, A High, K Maclennan, S Berri, P Chengot, ...
The Journal of Molecular Diagnostics 14 (2), 104-111, 2012
672012
Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation
E Bayman, RJD Prestwich, R Speight, L Aspin, L Garratt, S Wilson, ...
Clinical oncology 26 (10), 636-642, 2014
612014
Phase 2, open-label, 1: 1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent …
A Ruzsa, M Sen, M Evans, LW Lee, K Hideghety, S Rottey, P Klimak, ...
Investigational new drugs 32, 1278-1284, 2014
582014
Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions
E Ermiş, M Teo, KE Dyker, C Fosker, M Sen, RJD Prestwich
Radiation Oncology 10, 1-9, 2015
542015
The role of split-course hypofractionated palliative radiotherapy in head and neck cancer
KN Kancherla, DC Oksuz, RJD Prestwich, C Fosker, KE Dyker, CC Coyle, ...
Clinical Oncology 23 (2), 141-148, 2011
512011
Assessment of outcomes with delayed 18F-FDG PET-CT response assessment in head and neck squamous cell carcinoma
F Slevin, M Subesinghe, S Ramasamy, M Sen, AF Scarsbrook, ...
The British Journal of Radiology 88 (1052), 20140592, 2015
462015
The prognostic role of the neutrophil-to-lymphocyte ratio in oropharyngeal carcinoma treated with chemoradiotherapy
CA Young, LJ Murray, E Karakaya, HH Thygesen, M Sen, RJD Prestwich
Clinical Medicine Insights: Oncology 8, CMO. S15476, 2014
462014
Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma
RJD Prestwich, M Subesinghe, A Gilbert, FU Chowdhury, M Şen, ...
Clinical radiology 67 (10), 966-975, 2012
442012
Improving target definition for head and neck radiotherapy: a place for magnetic resonance imaging and 18-fluoride fluorodeoxyglucose positron emission tomography?
RJD Prestwich, J Sykes, B Carey, M Sen, KE Dyker, AF Scarsbrook
Clinical Oncology 24 (8), 577-589, 2012
402012
Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan
I Oztop, B Demirkan, A Yaren, O Tarhan, B Sengul, C Ulukus, D Akin, ...
Tumori Journal 90 (5), 514-516, 2004
402004
Long-term swallow function after chemoradiotherapy for oropharyngeal cancer: the influence of a prophylactic gastrostomy or reactive nasogastric tube
RJD Prestwich, MTW Teo, A Gilbert, G Williams, KE Dyker, M Sen
Clinical Oncology 26 (2), 103-109, 2014
382014
Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy—Update of the EORTC QLQ‐H&N35, Phase I
S Singer, JI Arraras, I Baumann, A Boehm, WC Chie, R Galalae, ...
Head & neck 35 (9), 1331-1338, 2013
382013
The system can't perform the operation now. Try again later.
Articles 1–20